Driving vascular endothelial cell fate of human multipotent Isl1 + heart progenitors with VEGF modified mRNA

Cell Research

Volumn 23, Issue 10, 2013, Pages 1172-1186

  Lui, Kathy O ^a,b,c   Zangi, Lior ^a,b,d   Silva, Eduardo A ^e,f   Bu, Lei ^a,b,c   Sahara, Makoto ^a,b   Li, Ronald A ^c,g   Mooney, David J ^e   Chien, Kenneth R ^a,b,h  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Harvard University   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD UNIVERSITY   (United States)

^f University of California   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h KAROLINSKA INSTITUTE   (Sweden)

Author keywords

cardiovascular progenitors; endothelial cells; Isl1; mRNA; VEGF A

Indexed keywords

MAMMALIA;

INSULIN GENE ENHANCER BINDING PROTEIN ISL 1; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1; LIM HOMEODOMAIN PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; VASCULOTROPIN A;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART MUSCLE; HUMAN; METABOLISM; PRENATAL DEVELOPMENT; STEM CELL; UPREGULATION;

CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HUMANS; LIM-HOMEODOMAIN PROTEINS; MYOCARDIUM; RNA, MESSENGER; STEM CELLS; TRANSCRIPTION FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885172335     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.112     Document Type: Article

References (41)

1. Dyer LA, Kirby ML. The role of secondary heart field in cardiac development. Dev Biol 2009; 336:137-144.
2. Bussmann J, Bakkers J, Schulte-Merker S. Early endocardial morphogenesis requires Scl/Tal1. PLoS Genet 2007; 3:e140.
3. Schoenebeck JJ, Keegan BR, Yelon D. Vessel and blood specification override cardiac potential in anterior mesoderm. Dev Cell 2007; 13:254-267.
4. Lough J, Sugi Y. Endoderm and heart development. Dev Dyn 2000; 217:327-342.
5. Wei Y,Mikawa T. Fate diversity of primitive streak cells during heart field formation in ovo. Dev Dyn 2000; 219:505-513.
6. Milgrom-Hoffman M, Harrelson Z, Ferrara N, Zelzer E, Evans SM, Tzahor E. The heart endocardium is derived from vascular endothelial progenitors. Development 2011; 138:4777-4787.
7. Red-Horse K, Ueno H, Weissman IL, Krasnow MA. Coronary arteries form by developmental reprogramming of venous cells. Nature 2010; 464:549-553.
8. Wu B, Zhang Z, Lui W, et al.Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell 2012; 151:1083-1096.
9. Sizarov A, Lamers WH, Mohun TJ, Brown NA, Anderson RH, Moorman AF. Three-dimensional and molecular analysis of the arterial pole of the developing human heart. J Anat 2012; 220:336-349.
10. Laugwitz KL, Moretti A, Lam J, et al.Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005; 433:647-653.
11. Moretti A, Caron L, Nakano A, et al.Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006; 127:1151-1165.
12. Garcia-Martinez V, Schoenwolf GC. Primitive-streak origin of the cardiovascular system in avian embryos. Dev Biol 1993; 159:706-719.
13. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005; 6:826-835.
14. Cai CL, Liang X, Shi Y, et al.Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003; 5:877-889.
15. Sun Y, Liang X, Najafi N, et al.Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev Biol 2007; 304:286-296.
16. Bu L, Jiang X, Martin-Puig S, et al.Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009; 460:113-117.
17. Zangi L, Lui KO, von Gise A, et al.Modified RNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat Biotechnol 2013 Sep 8. doi:10.1038/nbt.2682 18 Martin-Puig S, Wang Z, Chien KR. Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell 2008; 2:320-331.
18. Stankunas K, Ma GK, Kuhnert FJ, Kuo CJ, Chang CP. VEGF signaling has distinct spatiotemporal roles during heart valve development. Deve Biol 2010; 347:325-336.
19. Wagner N, Wagner KD, Theres H, Englert C, Schedl A, Scholz H. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. Genes Dev 2005; 19:2631-2642.
20. Diez M, Musri MM, Ferrer E, Barbera JA, Peinado VI. Endothelial progenitor cells undergo an endothelial-to-mesenchymal transition-like process mediated by TGFbetaRI. Cardiovasc Res 2010; 88:502-511.
21. Zeisberg EM, Tarnavski O, Zeisberg M, et al.Endothelial-tomesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952-961.
22. Kormann MS, Hasenpusch G, Aneja MK, et al.Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 2011; 29:154-157.
23. Warren L, Manos PD, Ahfeldt T, et al.Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2011; 7:618-630.
24. Adini A, Fainaru O, Udagawa T, Connor KM, Folkman J, D'Amato RJ. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo. J Immunol Methods 2009; 342:78-81.
25. De Val S, Black BL. Transcriptional control of endothelial cell development. Dev Cell 2009; 16:180-195.
26. Lyden D, Young AZ, Zagzag D, et al.Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999; 401:670-677.
27. Kume T, Jiang H, Topczewska JM, Hogan BL. The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis. Genes Dev 2001; 15:2470-2482.
28. Ferdous A, Caprioli A, Iacovino M, et al.Nkx2-5 transactivates the Ets-related protein 71 gene and specifies an endothelial/endocardial fate in the developing embryo. Proc Natl Acad Sci USA 2009; 106:814-819
29. Lee D, Park C, Lee H, et al.ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification. Cell Stem Cell 2008; 2:497-507
30. Rossig L, Urbich C, Brühl T, et al.Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 2005; 201:1825-1835
31. Zhou B, Pu WT. Genetic Cre-loxP assessment of epicardial cell fate using Wt1-driven Cre alleles. Circ Res 2012; 111:e276-e280.
32. Giordano FJ, Gerber HP, Williams SP, et al.A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 2001; 98:5780-5785.
33. Barzelay A, Hochhauser E, Entin-Meer M, et al.Islet-1 gene delivery improves myocardial performance after experimental infarction. Atherosclerosis 2012; 223:284-290.
34. Hao X, Månsson-Broberg A, Grinnemo KH, et al.Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model. Cardiovasc Res 2007; 73:481-487.
35. Eppler SM, Combs DL, Henry TD, et al.A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther 2002; 72:20-32.
36. Patterson C, Runge MS. Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: moving on down the road. Circulation 2000; 102:940-942.
37. Svensson EC, Marshall DJ, Woodard K, et al.Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adenoassociated virus vectors. Circulation 1999; 99:201-205.
38. Kobayashi M, Inoue K, Warabi E, Minami T, Kodama T. A simple method of isolating mouse aortic endothelial cells. J Atheroscler Thromb 2005; 12:138-142.
39. Ingram DA, Mead LE, Tanaka H, et al.Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104:2752-2760.
40. Silva EA, Kim ES, Kong HJ, Mooney DJ. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci USA 2008; 105:14347-14352.
41. Yoder MC, Mead LE, Prater D, et al.Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109:1801-1809.